- Home
- MARPS vs FBRX Comparison
MARPS vs FBRX Comparison
Compare MARPS & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MARPS
- FBRX
- Stock Information
- Founded
- MARPS 1956
- FBRX N/A
- Country
- MARPS United States
- FBRX United States
- Employees
- MARPS N/A
- FBRX N/A
- Industry
- MARPS Oil & Gas Production
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- MARPS Energy
- FBRX Health Care
- Exchange
- MARPS Nasdaq
- FBRX Nasdaq
- Market Cap
- MARPS 7.9M
- FBRX 8.3M
- IPO Year
- MARPS N/A
- FBRX N/A
- Fundamental
- Price
- MARPS $3.78
- FBRX $18.75
- Analyst Decision
- MARPS
- FBRX Strong Buy
- Analyst Count
- MARPS 0
- FBRX 3
- Target Price
- MARPS N/A
- FBRX $77.58
- AVG Volume (30 Days)
- MARPS 6.3K
- FBRX 1.7M
- Earning Date
- MARPS 01-01-0001
- FBRX 11-14-2024
- Dividend Yield
- MARPS 9.42%
- FBRX N/A
- EPS Growth
- MARPS N/A
- FBRX N/A
- EPS
- MARPS 0.36
- FBRX N/A
- Revenue
- MARPS $1,042,513.00
- FBRX N/A
- Revenue This Year
- MARPS N/A
- FBRX N/A
- Revenue Next Year
- MARPS N/A
- FBRX N/A
- P/E Ratio
- MARPS $10.60
- FBRX N/A
- Revenue Growth
- MARPS N/A
- FBRX N/A
- 52 Week Low
- MARPS $3.77
- FBRX $4.11
- 52 Week High
- MARPS $6.50
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- MARPS 40.06
- FBRX 52.67
- Support Level
- MARPS $3.98
- FBRX $18.33
- Resistance Level
- MARPS $3.87
- FBRX $24.64
- Average True Range (ATR)
- MARPS 0.06
- FBRX 3.23
- MACD
- MARPS -0.00
- FBRX -0.99
- Stochastic Oscillator
- MARPS 3.45
- FBRX 8.56
About MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).